Stay updated on Pembrolizumab for HNSCC Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HNSCC Residual Disease Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.5 to v3.6.6, indicating a minor version update in the page documentation.
    Difference
    0.1%
    Check dated 2026-08-29T18:59:59.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a small internal release update to the page's versioning metadata.
    Difference
    0.1%
    Check dated 2026-08-08T22:27:50.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.4, representing a minor page update with no change to study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-07-25T16:53:12.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.3, replacing the previous Revision: v3.6.2; this reflects a small software version update tied to the page rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-07-04T03:58:30.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.0 to v3.6.2. This indicates an updated version of the ClinicalTrials.gov record, suggesting minor edits or corrections to the study information.
    Difference
    0.1%
    Check dated 2026-06-27T02:13:38.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    Enrollment status was updated to no longer recruiting participants. New navigation items such as How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.6%
    Check dated 2026-06-12T16:43:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HNSCC Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HNSCC Residual Disease Clinical Trial page.